Tag: Prescription Drugs
Continuing Blood Pressure Meds Safe for Those With COVID-19
No difference in outcomes seen among hospitalized COVID-19 patients continuing, discontinuing renin-angiotensin system inhibitors
USPSTF Affirms Evidence-Based Methods for Smoking Cessation
Behavioral and pharmacotherapy interventions, alone or in combination, recommended; evidence insufficient for e-cigarettes
Bupropion-Naltrexone Bests Placebo in Methamphetamine Use Disorder
Response was low but higher with naltrexone-bupropion than placebo during 12-week, two-stage trial
Stopping RAS Inhibitors May Worsen Outcomes in CKD
Stopping therapy tied to lower risk for dialysis, but higher risk for cardiovascular events and death
Inhaled Treprostinil Beneficial in Pulmonary Hypertension
Exercise capacity improved, clinical worsening reduced for patients with pulmonary HTN due to interstitial lung disease
Women Must Get Abortion Pill in Person: U.S. Supreme Court
Similar in-person rules for other medications have been suspended during the pandemic
Experimental Drug for Alzheimer Disease Shows Promise
After six to 12 months of treatment with the drug, patients no longer had amyloid protein plaques
Hydroxychloroquine Level Tied to Thrombosis Risk in Lupus
Rate of thrombotic events lower for patients with mean HCQ blood levels >1,068 versus <648 ng/mL
Sitagliptin Promising Addition for Preventing Acute GVHD
Low incidence of grade II to IV acute GVHD seen in patients undergoing myeloablative allogeneic hematopoietic stem cell transplantation
Drug Makers Raise Prices on 500 Prescription Drugs
AbbVie, Bristol Myers Squibb, GlaxoSmithKline, and Pfizer among companies raising their prices by a median of 4.6 percent
